{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T09:21:27Z","timestamp":1724577687235},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","medical-hypotheses.com","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.mehy.2016.09.021","type":"journal-article","created":{"date-parts":[[2016,9,24]],"date-time":"2016-09-24T13:45:59Z","timestamp":1474724759000},"page":"35-38","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity"],"prefix":"10.1016","volume":"96","author":[{"given":"Natalia","family":"Schlabritz-Loutsevitch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadezhda","family":"German","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gary","family":"Ventolini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eneko","family":"Larumbe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques","family":"Samson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mehy.2016.09.021_b0005","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/head.12570","article-title":"Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it\u2019s been","volume":"55","author":"Baron","year":"2015","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0010","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1515\/jbcpp-2015-0059","article-title":"Cannabinoids in the management of chronic pain: a front line clinical perspective","volume":"27","author":"Lynch","year":"2016","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0015","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/bph.12944","article-title":"Are cannabidiol and Delta(9) -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review","volume":"172","author":"McPartland","year":"2015","journal-title":"Br J Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0020","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","article-title":"The endocannabinoid system as an emerging target of pharmacotherapy","volume":"58","author":"Pacher","year":"2006","journal-title":"Pharmacol Rev"},{"issue":"5","key":"10.1016\/j.mehy.2016.09.021_b0025","first-page":"373","article-title":"Cannabinoids for the treatment of inflammation","volume":"8","author":"Ashton","year":"2007","journal-title":"Curr Opin Investig Drugs"},{"issue":"7","key":"10.1016\/j.mehy.2016.09.021_b0030","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1476-5381.2011.01343.x","article-title":"Endocannabinoids and traumatic brain injury","volume":"163","author":"Shohami","year":"2011","journal-title":"Br J Pharmacol"},{"issue":"4","key":"10.1016\/j.mehy.2016.09.021_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.aat.2013.10.004","article-title":"Targeting the cannabinoid system for pain relief?","volume":"51","author":"Chiou","year":"2013","journal-title":"Acta Anaesthesiol Taiwan"},{"issue":"1","key":"10.1016\/j.mehy.2016.09.021_b0040","doi-asserted-by":"crossref","first-page":"134","DOI":"10.2174\/1874467210902010134","article-title":"The role of the endogenous cannabinoid system in peripheral analgesia","volume":"2","author":"Guindon","year":"2009","journal-title":"Curr Mol Pharmacol"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0045","first-page":"198","article-title":"Clinical endocannabinoid deficiency (CECD) revisited: can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"35","author":"Smith","year":"2014","journal-title":"Neuro Endocrinol Lett"},{"issue":"1\u20132","key":"10.1016\/j.mehy.2016.09.021_b0050","first-page":"31","article-title":"Clinical endocannabinoid deficiency (CECD): can this concept explain therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?","volume":"25","author":"Russo","year":"2004","journal-title":"Neuro Endocrinol Lett"},{"issue":"21","key":"10.1016\/j.mehy.2016.09.021_b0055","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1001\/jama.2016.6458","article-title":"Trends in obesity among adults in the United States, 2005 to 2014","volume":"315","author":"Flegal","year":"2016","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0060","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1001\/jama.2009.2014","article-title":"Prevalence and trends in obesity among US adults, 1999\u20132008","volume":"303","author":"Flegal","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.mehy.2016.09.021_b0065","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1053\/j.semperi.2011.05.019","article-title":"Maternal obesity and stillbirth","volume":"35","author":"Salihu","year":"2011","journal-title":"Semin Perinatol"},{"issue":"5 Suppl","key":"10.1016\/j.mehy.2016.09.021_b0070","doi-asserted-by":"crossref","first-page":"1242S","DOI":"10.1093\/ajcn\/71.5.1242s","article-title":"Obesity and pregnancy: complications and cost","volume":"71","author":"Galtier-Dereure","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.mehy.2016.09.021_b0075","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fnins.2015.00194","article-title":"The role of maternal obesity in the risk of neuropsychiatric disorders","volume":"9","author":"Rivera","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/j.mehy.2016.09.021_b0080","doi-asserted-by":"crossref","first-page":"f4539","DOI":"10.1136\/bmj.f4539","article-title":"Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1 323 275 person years","volume":"347","author":"Reynolds","year":"2013","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mehy.2016.09.021_b0085","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2393-14-74","article-title":"A complex intervention to improve pregnancy outcome in obese women; the UPBEAT randomised controlled trial","volume":"14","author":"Briley","year":"2014","journal-title":"BMC Pregnancy Childbirth"},{"issue":"5","key":"10.1016\/j.mehy.2016.09.021_b0090","doi-asserted-by":"crossref","first-page":"e95132","DOI":"10.1371\/journal.pone.0095132","article-title":"Interventions to reduce and prevent obesity in pre-conceptual and pregnant women: a systematic review and meta-analysis","volume":"9","author":"Agha","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"10.1016\/j.mehy.2016.09.021_b0095","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1017\/S0029665113003418","article-title":"PUFA-derived endocannabinoids: an overview","volume":"72","author":"Cascio","year":"2013","journal-title":"Proc Nutr Soc"},{"issue":"2","key":"10.1016\/j.mehy.2016.09.021_b0100","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.phrs.2009.02.010","article-title":"The endocannabinoid system: its general strategy of action, tools for its pharmacological manipulation and potential therapeutic exploitation","volume":"60","author":"Di Marzo","year":"2009","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.mehy.2016.09.021_b0105","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.prostaglandins.2012.11.005","article-title":"Fat to treat fat: emerging relationship between dietary PUFA, endocannabinoids, and obesity","volume":"104\u2013105","author":"Kim","year":"2013","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"10.1016\/j.mehy.2016.09.021_b0110","doi-asserted-by":"crossref","DOI":"10.1002\/oby.20728","article-title":"Influence of dietary fat intake on the endocannabinoid system in lean and obese subjects","author":"Engeli","year":"2014","journal-title":"Obesity (Silver Spring)"},{"issue":"11","key":"10.1016\/j.mehy.2016.09.021_b0115","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/j.placenta.2013.08.007","article-title":"Endocannabinoid crosstalk between placenta and maternal fat in a baboon model (Papio spp.) of obesity","volume":"34","author":"Brocato","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/j.mehy.2016.09.021_b0120","doi-asserted-by":"crossref","first-page":"361895","DOI":"10.1155\/2013\/361895","article-title":"Fatty Acid modulation of the endocannabinoid system and the effect on food intake and metabolism","volume":"2013","author":"Naughton","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/j.mehy.2016.09.021_b0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3389\/fgene.2011.00057","article-title":"Mechanisms involved in the selective transfer of long chain polyunsaturated Fatty acids to the fetus","volume":"2","author":"Gil-Sanchez","year":"2011","journal-title":"Front Genet"},{"issue":"4","key":"10.1016\/j.mehy.2016.09.021_b0130","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jada.2008.12.022","article-title":"A systemic review of the roles of n-3 fatty acids in health and disease","volume":"109","author":"Riediger","year":"2009","journal-title":"J Am Diet Assoc"},{"issue":"6","key":"10.1016\/j.mehy.2016.09.021_b0135","doi-asserted-by":"crossref","first-page":"e67791","DOI":"10.1371\/journal.pone.0067791","article-title":"Transgenic increase in N-3\/n-6 Fatty Acid ratio reduces maternal obesity-associated inflammation and limits adverse developmental programming in mice","volume":"8","author":"Heerwagen","year":"2013","journal-title":"PLoS ONE"},{"issue":"8","key":"10.1016\/j.mehy.2016.09.021_b0140","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/jn.109.104844","article-title":"Endocannabinoids may mediate the ability of (n-3) fatty acids to reduce ectopic fat and inflammatory mediators in obese Zucker rats","volume":"139","author":"Batetta","year":"2009","journal-title":"J Nutr"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0145","doi-asserted-by":"crossref","first-page":"e89566","DOI":"10.1371\/journal.pone.0089566","article-title":"Care and feeding of the endocannabinoid system: a systematic review of potential clinical interventions that upregulate the endocannabinoid system","volume":"9","author":"McPartland","year":"2014","journal-title":"PLoS ONE"},{"issue":"9","key":"10.1016\/j.mehy.2016.09.021_b0150","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1517\/13543784.2012.704019","article-title":"Second generation CB1 receptor blockers and other inhibitors of peripheral endocannabinoid overactivity and the rationale of their use against metabolic disorders","volume":"21","author":"Silvestri","year":"2012","journal-title":"Expert Opin Investig Drugs"},{"issue":"8","key":"10.1016\/j.mehy.2016.09.021_b0155","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1136\/gut.2008.148791","article-title":"Emerging role of cannabinoids in gastrointestinal and liver diseases: basic and clinical aspects","volume":"57","author":"Izzo","year":"2008","journal-title":"Gut"},{"issue":"7","key":"10.1016\/j.mehy.2016.09.021_b0160","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/ibd.21539","article-title":"Maternal obesity induces sustained inflammation in both fetal and offspring large intestine of sheep","volume":"17","author":"Yan","year":"2011","journal-title":"Inflamm Bowel Dis"},{"issue":"2","key":"10.1016\/j.mehy.2016.09.021_b0165","first-page":"1","article-title":"8 years - autism and developmental disabilities monitoring network, 11 sites, United States, 2010","volume":"63","author":"Prevalence of autism spectrum disorder among children aged","year":"2014","journal-title":"MMWR Surveill Summ"},{"issue":"7","key":"10.1016\/j.mehy.2016.09.021_b0170","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/npp.2011.34","article-title":"Deletion of CB2 cannabinoid receptor induces schizophrenia-related behaviors in mice","volume":"36","author":"Ortega-Alvaro","year":"2011","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.mehy.2016.09.021_b0175","first-page":"1000193","article-title":"Comment on the recent publication in the New England journal of medicine: trends in mental health care among children and adolescents\u201d (Olfson et al., 2015)","volume":"4","author":"Natalia Schlabritz-Loutsevitch","year":"2015","journal-title":"J Depression Anxiety"},{"issue":"6","key":"10.1016\/j.mehy.2016.09.021_b0180","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2125.1978.tb01667.x","article-title":"Bronchodilator effect of delta1-tetrahydrocannabinol","volume":"5","author":"Hartley","year":"1978","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.mehy.2016.09.021_b0185","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev.pa.20.040180.001055","article-title":"Potential therapeutic usefulness of marijuana","volume":"20","author":"Lemberger","year":"1980","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"4","key":"10.1016\/j.mehy.2016.09.021_b0190","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-3016.2009.01034.x","article-title":"Maternal obesity in pregnancy and respiratory health in early childhood","volume":"23","author":"Haberg","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"issue":"5","key":"10.1016\/j.mehy.2016.09.021_b0195","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1111\/j.1365-2222.2008.03179.x","article-title":"High-fat feeding redirects cytokine responses and decreases allergic airway eosinophilia","volume":"39","author":"de Vries","year":"2009","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.mehy.2016.09.021_b0200","doi-asserted-by":"crossref","DOI":"10.1111\/1440-1681.12166","article-title":"Regulation of fetal lung development in response to maternal overnutrition","author":"Lock","year":"2013","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"6","key":"10.1016\/j.mehy.2016.09.021_b0205","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1111\/dom.12646","article-title":"Endocannabinoid regulation of beta-cell functions: implications for glycaemic control and diabetes","volume":"18","author":"Jourdan","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"45","key":"10.1016\/j.mehy.2016.09.021_b0210","doi-asserted-by":"crossref","first-page":"E6185","DOI":"10.1073\/pnas.1519040112","article-title":"Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture","volume":"112","author":"Malenczyk","year":"2015","journal-title":"Proc Nat Acad Sci USA"},{"key":"10.1016\/j.mehy.2016.09.021_b0215","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.yhbeh.2015.06.015","article-title":"Developmental programming by maternal obesity in 2015: Outcomes, mechanisms, and potential interventions","volume":"76","author":"Penfold","year":"2015","journal-title":"Horm Behav"},{"issue":"2","key":"10.1016\/j.mehy.2016.09.021_b0220","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/ijo.2015.178","article-title":"The early origins of obesity and insulin resistance: timing, programming and mechanisms","volume":"40","author":"Nicholas","year":"2016","journal-title":"Int J Obes (Lond)"},{"issue":"1","key":"10.1016\/j.mehy.2016.09.021_b0225","doi-asserted-by":"crossref","first-page":"S94","DOI":"10.1016\/j.ajog.2013.10.196","article-title":"163: Fetal gender-specific placental \u201cendocannabinoidome\u201d in maternal obesity","volume":"210","author":"Schlabritz-Loutsevitch","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.mehy.2016.09.021_b0230","author":"Cohen","year":"1998"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0306987716302808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,14]],"date-time":"2019-09-14T00:06:28Z","timestamp":1568419588000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0306987716302808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":46,"alternative-id":["S0306987716302808"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.021","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fetal Syndrome of Endocannabinoid Deficiency (FSECD) In Maternal Obesity","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2016.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}